A study of herbal remedies for memory complaints

Journal of Neuropsychiatry and Clinical Neurosciences

Volumn 22, Issue 3, 2010, Pages 345-347

  Serby, Michael J ^a,b   Yhap, Christine ^a   Landron, Eva Y ^a  

^a BETH ISRAEL MEDICAL CENTER   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GINKGO BILOBA EXTRACT; HERBACEOUS AGENT; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLSERINE;

ARTICLE; BRAIN HEMORRHAGE; DEMENTIA; DRUG COST; DRUG INFORMATION; DRUG MARKETING; DRUG SAFETY; GASTROINTESTINAL DISEASE; GINKGO BILOBA; HEADACHE; HEPATITIS; HERBAL MEDICINE; HUMAN; HYPERTENSION; HYPOGLYCEMIA; MEDICAL HISTORY; MEMORY DISORDER; PRIORITY JOURNAL; SEROTONIN SYNDROME;

EID: 77955455927     PISSN: 08950172     EISSN: 15457222     Source Type: Journal    
DOI: 10.1176/jnp.2010.22.3.345     Document Type: Article

References (15)

1. Cavaliere C, Rea P, Lynch ME, et al: Herbal supplement sales experience slight increase in 2008. HerbalGram 2009; 82:58-61
2. Barnes PM, Bloom B, Nahin R: CDC National Health Statistics Report #12. Complementary and Alternative Medicine Use Among Adults and Children: United States, 2007. Dec 10, 2008. Available at http://nccam.nih.gov/news/2008/nhsr12. pdf
3. Robinson A, McGrail MR: Disclosure of CAM use to medical practitioners: a review of qualitative and quantitative studies. Complement Ther Med 2004; 12:90-98 (Pubitemid 39618835)
4. DeKosky ST, Fitzpatrick A, Ives DG, et al: The Ginkgo Evaluation of Memory (GEM) study: design and baseline data of a randomized trial of ginkgo biloba extract in prevention of dementia. JAMA 2008; 300:2253-2262
5. Solomon PR, Adams F, Silver A, et al: Ginkgo for memory enhancement: a randomized controlled trial. JAMA 2002; 288:835-840
6. Etienne P, Dastoor D, Gauthier S, et al: Alzheimer disease: lack of effect of lecithin treatment for 3 months. Neurology 1981; 31:1552-1554 (Pubitemid 12242012)
7. Brinkman SD, Pomara N, Goodnick PJ, et al: A dose-ranging study of lecithin in the treatment of primary degenerative dementia (Alzheimer disease). J Clin Psychopharmacol 1982; 2:281-285 (Pubitemid 12062846)
8. Drachman DA, Glosser G, Fleming P, et al: Memory decline in the aged: treatment with lecithin and physostigmine. Neurology 1982; 32:944-950 (Pubitemid 12049455)
9. Dysken MW, Fovall P, Harris CM, et al: Lecithin administration in Alzheimer dementia. Neurology 1982; 32:1203-1204
10. Weintraub S, Mesulan MM, Auty R, et al: Lecithin in the treatment of Alzheimer's disease. Arch Neurol 1983; 40:527-528
11. Heyman A, Schmechel D, Wilkinson W, et al: Failure of longterm high-dose lecithin to retard progression of early-onset Alzheimer's disease. J Neural Transm Suppl 1987; 24:279-286
12. Schreiber S, Kampf-Sherf O, Gorfine M, et al: An open trial of plant-source derived phosphatydilserine for treatment of age-related cognitive decline. J Psychiatry Relat Sci 2000; 37:302-307
13. Engel RR, Satzger W, Günther W, et al: Double-blind cross-over study of phosphatidylserine vs placebo in patients with early dementia of the Alzheimer type. Eur Neuropsychopharmacol 1992; 2:149-155
14. Delwaide PJ, Gyselynck-Mambourg AM, Hurlet A, et al: Double-blind randomized controlled study of phosphatidylserine in senile demented patients. Acta Neurol Scand 1986; 73:136-140 (Pubitemid 16124005)
15. World Health Organization: WHO Monographs on Selected Medicinal Plants, Volume 1 and Volume 2. Geneva, Switzerland, World Health Organization, 1999